Stock NGNE NEUROGENE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Neurogene Inc.

Equities

NGNE

US64135M1053

Real-time Estimate Cboe BZX
Other stock markets
 01:40:14 2024-05-15 pm EDT 		5-day change 1st Jan Change
33.05 USD +4.75% Intraday chart for Neurogene Inc. +0.43% +70.49%
May. 10 Neurogene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 07 Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of Ngn-401 Gene Therapy for Rett Syndrome During Asgct Annual Meeting CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NEUROGENE INC.
Other Biotechnology & Medical Research
+4.72%+0.43%+70.49% - - 406M
Neutral
Bullish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. NGNE Stock
  4. Charts Neurogene Inc.
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW